[1]
2021. Bufalin inhibits the growth and epithelial to mesenchymal transition of human gastric cancer cells via modulation of MEK/ERK pathway. Bangladesh Journal of Pharmacology. 16, 1 (Jan. 2021), 27–33. DOI:https://doi.org/10.3329/bjp.v16i1.50548.